Juan P. Tartari

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Plasma Aβ42/Aβ40 determined by mass spectrometry is associated with longitudinal changes in amyloid accumulation, brain atrophy, and conversion to mild cognitive impairment due to Alzheimer's disease in individuals with subjective cognitive decline: 5-year follow-up of the FACEHBI cohort.

Plasma Aβ42/Aβ40 determined by mass spectrometry is associated with longitudinal changes in amyloid accumulation, brain atrophy, and conversion to mild cognitive impairment due to Alzheimer's disease in individuals with subjective cognitive decline: 5-year follow-up of the FACEHBI cohort.

Journal: The journal of prevention of Alzheimer's disease

Published: June 12, 2025

Efficacy and impact of spousal support groups in enhancing the well-being of caring in early onset dementia: Lessons learned from the ACE Alzheimer center Barcelona.

Efficacy and impact of spousal support groups in enhancing the well-being of caring in early onset dementia: Lessons learned from the ACE Alzheimer center Barcelona.

Journal: Dementia (London, England)

Published: April 28, 2025

Randomized phase 2a trial assessing a novel septin molecular glue in Alzheimer's disease.

Randomized phase 2a trial assessing a novel septin molecular glue in Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: April 08, 2025

Quantification of baseline amyloid PET in individuals with subjective cognitive decline can identify risk of amyloid accumulation and cognitive worsening: the FACEHBI study.

Quantification of baseline amyloid PET in individuals with subjective cognitive decline can identify risk of amyloid accumulation and cognitive worsening: the FACEHBI study.

Journal: European journal of nuclear medicine and molecular imaging

Published: December 20, 2024

Linking genomic and proteomic signatures to brain amyloid burden: insights from GR@ACE/DEGESCO.

Linking genomic and proteomic signatures to brain amyloid burden: insights from GR@ACE/DEGESCO.

Journal: Functional & integrative genomics

Published: December 03, 2024

FACEmemory®, an Innovative Self-Administered Online Memory Assessment Tool.

FACEmemory®, an Innovative Self-Administered Online Memory Assessment Tool.

Journal: Journal of clinical medicine

Published: October 30, 2024

Pharmacodynamic and Clinical Effects of Ginkgo Biloba Extract EGb 761 and Its Phytochemical Components in Alzheimer's Disease.

Pharmacodynamic and Clinical Effects of Ginkgo Biloba Extract EGb 761 and Its Phytochemical Components in Alzheimer's Disease.

Journal: Journal of Alzheimer's disease : JAD

Published: October 18, 2024

Changes in choroidal thickness quantified by Optical Coherence Tomography across cognitive impairment: data from the NORFACE cohort.

Changes in choroidal thickness quantified by Optical Coherence Tomography across cognitive impairment: data from the NORFACE cohort.

Journal: Alzheimer's research & therapy

Published: September 13, 2024

Head-to-head comparison of tau PET tracers [18F]PI-2620 and [18F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohort.

Head-to-head comparison of tau PET tracers [18F]PI-2620 and [18F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohort.

Journal: Alzheimer's research & therapy

Published: July 15, 2024

Exploring sex differences in Alzheimer's disease: a comprehensive analysis of a large patient cohort from a memory unit.

Exploring sex differences in Alzheimer's disease: a comprehensive analysis of a large patient cohort from a memory unit.

Journal: Alzheimer's research & therapy

Published: February 05, 2024

Clinical value of plasma pTau181 to predict Alzheimer's disease pathology in a large real-world cohort of a memory clinic.

Clinical value of plasma pTau181 to predict Alzheimer's disease pathology in a large real-world cohort of a memory clinic.

Journal: EBioMedicine

Published: December 22, 2023

Automated Classification of Cognitive Decline and Probable Alzheimer's Dementia Across Multiple Speech and Language Domains.

Automated Classification of Cognitive Decline and Probable Alzheimer's Dementia Across Multiple Speech and Language Domains.

Journal: American journal of speech-language pathology

Published: July 24, 2023

Showing 1-12 of 36

Last Updated: 09/26/2026